Science Explorer Back to mapMap
Discussion
Company · Hayward · United States

Chrono Therapeutics (United States)

Research works
13
▲ 17% vs 2018-21
Citations
292
23.3 per fractional work
Top-10% rate
7.0%
all institutions 10.0%
Open access
39%
world 40%
International
12%
world 18%
Chrono Therapeutics (United States)

Not ranked overall: Chrono Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Chrono Therapeutics (United States) work in?

In all years, 65% of research at Chrono Therapeutics (United States) is in Life Sciences, 27% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (56%), Medicine (27%), Immunology and Microbiology (7%). It does 2.3× the world's share of Life Sciences.

Life Sciences: 8 fractional works · 65.4% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 56.1% of its workMolecular Biology: 6 fractional works · 50.7% of its workGenetics: 0 fractional works · 2.6% of its workBiophysics: 0 fractional works · 1.4% of its workCancer Research: 0 fractional works · 1.4% of its workImmunology and Microbiology: 1 fractional works · 6.7% of its workImmunology: 1 fractional works · 6.7% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 2.6% of its workPharmaceutical Science: 0 fractional works · 2.6% of its workHealth Sciences: 3 fractional works · 27.5% of its workMedicine: 3 fractional works · 27.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 9.7% of its workOncology: 1 fractional works · 8.8% of its workEmergency Medicine: 0 fractional works · 3.2% of its workNeurology: 0 fractional works · 2.6% of its workSurgery: 0 fractional works · 1.7% of its workPharmacology: 0 fractional works · 0.6% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.4% of its workVeterinary: 0 fractional works · 0.1% of its workPhysical Sciences: 1 fractional works · 6.9% of its workChemistry: 1 fractional works · 4.5% of its workOrganic Chemistry: 0 fractional works · 4.0% of its workAnalytical Chemistry: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 2.0% of its workMaterials Chemistry: 0 fractional works · 1.4% of its workBiomaterials: 0 fractional works · 0.6% of its workEngineering: 0 fractional works · 0.4% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.2% of its workALL ITS WORKChronoTherapeutics…13fractional works, all years
Life Sciences65%Physical Sciences7%Health Sciences27%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology756.1%
    2. Immunology and Microbiology16.7%
    3. Pharmacology, Toxicology and Pharmaceutics02.6%
    1. Medicine327.4%
    2. Veterinary00.1%
    1. Chemistry14.5%
    2. Materials Science02.0%
    3. Engineering00.4%
    1. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Chrono Therapeutics (United States)?

The most cited paper from Chrono Therapeutics (United States) is "Nicotine replacement treatment, e-cigarettes and an online behavioural intervention to reduce relapse in recent ex-smokers: a multinational four-arm RCT" (Hayden J. McRobbie, Anna Phillips‐Waller, Catherine El Zerbi et al., 2020), with 8 citations. Next come "Liquid and Powder Jet Injectors in Drug Delivery: Mechanisms, Designs, and Applications" (8) and "Potency-optimized CD28-activating bispecific antibody for the targeted treatment of Nectin-4 positive cancers" (6).

Most cited papers
#PaperReleasedCitations
1 Nicotine replacement treatment, e-cigarettes and an online behavioural intervention to reduce relapse in recent ex-smokers: a multinational four-arm RCT Hayden J. McRobbie, Anna Phillips‐Waller, Catherine El Zerbi et al. · Health Technology Assessment Open access Dec 2020 8
2 Liquid and Powder Jet Injectors in Drug Delivery: Mechanisms, Designs, and Applications Anubhav Arora Book chapter 2017 8
3 Potency-optimized CD28-activating bispecific antibody for the targeted treatment of Nectin-4 positive cancers Manpreet Kaur, Katja Rüger, Elaine C Chen et al. · Journal for ImmunoTherapy of Cancer Open access Apr 2025 6
4 Comparative evaluation of cell-based assay technologies for scoring drug-induced condensation of SARS-CoV-2 nucleocapsid protein Rui Tong Quek, Cyna R. Shirazinejad, Christina L. Young et al. · SLAS DISCOVERY Open access Feb 2025 2
5 US immigration order strikes against biotech Jeremy M. Levin et al. · Nature Biotechnology 192 authors Mar 2017 2
All 5 most cited papers, with filters and sorting

Which research topics does Chrono Therapeutics (United States) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Advanced Biosensing Techniques and Applications and Click Chemistry and Applications.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 HER2/EGFR in Cancer Research Oncology 1 works
  3. 3 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  4. 4 Click Chemistry and Applications Organic Chemistry 0 works
  5. 5 Immunotherapy and Immune Responses Immunology 0 works
  6. 6 Immune Cell Function and Interaction Immunology 0 works
  7. 7 Single-cell and spatial transcriptomics Molecular Biology 0 works
  8. 8 Genomics and Chromatin Dynamics Molecular Biology 0 works
  9. 9 Advanced Fluorescence Microscopy Techniques Biophysics 0 works
  10. 10 interferon and immune responses Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.2%not open60.8%

World: 40% of research is openly available.

with international co-authors12.0%domestic only88.0%

World: 18% is written across borders.

How has Chrono Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 17% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Chrono Therapeutics (United States) as a percentage of every work published that year, 0.0000072% in 2024.

still counting0.000050%0.00010%0.00015%Chrono Therapeutics (United States)0.000014% in 2025200020102020

Fractional works of Chrono Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Hayward

All research institutions in Hayward

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Chrono Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.